Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Calypte Biomedical Corp.
Rapid HIV blood test passes Malaysian government evaluation
November 4th, 2005
Calypte Biomedical Corp. (HIV) has received notification that Aware BSP, its rapid blood test for HIV-1 and HIV-2 antibodies, has been successfully evaluated by government agencies in Malaysia. In Malaysia, favorable government evaluation is generally requested although not strictly required to market HIV tests. Aware BSP is a 20-minute rapid test designed to detect HIV antibodies in whole blood, serum, or plasma. It is one test in a line of three such assays, the other two being designed to detect HIV antibodies in oral fluid and urine. The health authorities in Malaysia have not evaluated non-blood HIV tests in the past, and are determining how...
Source: Biotech Law Weekly (2005-11-04)
|
